August 08, 2025

Unprompted Speech Changes Found in ME/CFS

Nearly 1 in 10 individuals with myalgic encephalomyelitis/chronic fatigue syndrome reported voice or speech changes in a recent survey, despite not being directly asked about these symptoms.

Conexiant

August 06, 2025

Not All Problematic Internet Use Is Equal, Expert Argues

Not all screen time is created equal. That’s the message from a recent editorial, which challenges the idea that all forms of problematic internet use led to the same cognitive consequences.

Conexiant

July 23, 2025

Are Wearables Mining the Mind?

As neurotech devices move from clinics to consumers, states are racing to safeguard brainwave data from earbuds, sleep trackers, and AI-powered apps—raising new questions about privacy, consent, and medical ethics.

KFF Health News

July 17, 2025

Semaglutide, Tirzepatide Linked to Lower Dementia Risk

Researchers found that semaglutide and tirzepatide were associated with reduced risks of dementia, stroke, and all-cause mortality in patients with type 2 diabetes and obesity.

Conexiant

July 14, 2025

Pegivirus in Brain Linked to Parkinson’s Disease

A new study identified human pegivirus in the brains and blood of patients with Parkinson’s disease, revealing virus-linked immune and gene expression changes that varied by genetic background.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

July 26, 2024

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

September 30, 2024

Can L-DOPA Protect Against nAMD?

Patients consistently treated with L-DOPA also had lower progression rates from intermediate AMD to nAMD compared to non-treated groups.

Conexiant